Tobacco Vaccine Could Be Reality Soon

The federal government is giving Texas A&M and a private company 40 million dollars to develop flu vaccines from tobacco. As David Pitman reports, the goal is to be able to respond to flu outbreaks with new vaccines quicker than current technology.


To embed this piece of audio in your site, please use this code:

<iframe src="" style="height: 115px; width: 100%;"></iframe>

Since the 1950’s, flu vaccines have been made from chicken eggs inoculated with the virus. But that can sometimes mean up to a six month wait for a vaccine, once a flu virus is isolated.

And if the eggs don’t produce the expected amount of vaccine, it can result in shortages — like it did with the H1N1 vaccine last fall.

Researchers at A&M, along with a company called g-con, hope to solve that problem by using tobacco to cultivate flu proteins. New vaccines could be developed within four to six weeks. And they wouldn’t have any nicotine.

The 40 million dollar grant from the Department of Defense would pay for 10 million doses of tobacco-based swine flu vaccine. Clinical trials on humans could happen sometime in the second half of next year. One of the lead researchers on the project says if all goes well, the tobacco-based vaccine facility could eventually pump out as many as a billion doses per month.

Subscribe to Today in Houston

Fill out the form below to subscribe our new daily editorial newsletter from the HPM Newsroom.

* required


David Pitman

David Pitman


David was HPM’s local Morning Edition host from 2009 to 2020 -- when he was moved to the position of Technical Director of Houston Matters with Craig Cohen, and Town Square with Ernie Manouse. David has extensive public and commercial broadcast journalism and production experience dating back to 1993 –...

More Information